92286-62-9

Usage

Uses

Used in Pharmaceutical Development:
HPCA is utilized as a candidate for the development of novel pharmaceutical drugs, particularly for neurodegenerative diseases and psychiatric disorders. Its neuroprotective properties make it a promising agent for conditions such as Alzheimer's disease, where it may help protect neurons from degeneration.
Used in Epilepsy Treatment:
In the field of neurology, HPCA is used as an anticonvulsant agent for the treatment of epilepsy. Its ability to reduce seizure activity makes it a potential therapeutic option for managing this neurological disorder.
Used in Schizophrenia Management:
HPCA is also considered for use in psychiatry as a treatment for schizophrenia. Its potential to alleviate symptoms associated with this psychiatric disorder positions it as a valuable asset in mental health care.
Used in Antioxidant and Anti-inflammatory Therapies:
Given its suggested antioxidant and anti-inflammatory effects, HPCA is explored for use in therapies aimed at reducing oxidative stress and inflammation, which are common pathological features in many diseases.
Used in Research:
In the scientific community, HPCA serves as a subject of research to further understand its mechanisms of action and to explore additional therapeutic applications, potentially leading to new treatment strategies for various conditions.

Upstream product

• 93041-45-3 3-(4-methoxy)-5-methylisoxazole-4-carboxylic acid 
• 92029-68-0 methyl 3-(4-methoxyphenyl)-5-methylisoxazole-4-carboxylate 
• 31709-47-4 3-(4-methoxyphenyl)isoxazol-5(4H)-one 
• 38435-51-7 N-hydroxy-4-methoxy-benzenecarboximidoyl chloride 
• 92961-55-2 4-(1-ethoxy-ethylidene)-3-(4-methoxy-phenyl)-4H-isoxazol-5-one 

Downstream Products

• 92545-94-3 3-(4-hydroxy-phenyl)-5-methyl-isoxazole-4-carbonyl chloride